AbbVie (ABBV) Dividends payables (2013 - 2015)
AbbVie (ABBV) posted quarterly Dividends payables of $924.0 million for Q4 2015, up 16.81% year-over-year from $791.0 million in Q4 2014, and up 16.81% quarter-over-quarter from $791.0 million in Q4 2014.
AbbVie (ABBV) Dividends payables (2013 - 2015) Analysis & Trends
AbbVie (ABBV) has reported Dividends payables for 3 consecutive years, with $924.0 million the latest figure, recorded in Q4 2015.
- In Q4 2015, Dividends payables rose 16.81% year-over-year to $924.0 million; the TTM figure through Dec 2015 stood at $924.0 million (up 16.81% YoY), while the FY2015 annual figure was $924.0 million, up 16.81% from the prior year.
- Dividends payables improved to $924.0 million in Q4 2015 per ABBV's latest filing, from $791.0 million in the prior quarter.
- Across five years, Dividends payables topped out at $924.0 million in Q4 2015 and bottomed at $643.0 million in Q4 2013.
- Historically, Dividends payables has averaged $786.0 million across 3 years, with a median of $791.0 million in 2014.
- Annual changes were most pronounced in 2014 — Dividends payables climbed 23.02% — and 2015, when it climbed 16.81%.
- AbbVie's Dividends payables stood at $643.0 million in 2013, then gained by 23.02% to $791.0 million in 2014, then gained by 16.81% to $924.0 million in 2015.
- Business Quant data shows ABBV's Dividends payables at $924.0 million in Q4 2015, $791.0 million in Q4 2014, and $643.0 million in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.03 Bn | 634.27 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.29 Bn | 463.72 Bn | 12.70 Bn | - |
| 3 | Merck | 380.80 Bn | 373.66 Bn | 12.21 Bn | 2.13 Bn |
| 4 | Novartis Ag | 302.80 Bn | 295.11 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 258.24 Bn | 253.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 237.40 Bn | 223.41 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 183.07 Bn | 179.89 Bn | 6.22 Bn | - |
| 8 | Pfizer | 161.54 Bn | 149.84 Bn | 10.94 Bn | 2.45 Bn |
| 9 | Gsk | 106.01 Bn | 101.85 Bn | 8.24 Bn | - |
| 10 | Sanofi | 55.05 Bn | 47.67 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 924.00 Mn |
| Dec 31, 2014 | 791.00 Mn |
| Dec 31, 2013 | 643.00 Mn |